Hillsdale Investment Management Inc. Has $827,000 Stock Position in Intuitive Surgical, Inc. $ISRG

Hillsdale Investment Management Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,460 shares of the medical equipment provider’s stock after selling 2,269 shares during the period. Hillsdale Investment Management Inc.’s holdings in Intuitive Surgical were worth $827,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of ISRG. Northwestern Mutual Wealth Management Co. boosted its position in Intuitive Surgical by 1,043.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock valued at $760,124,000 after purchasing an additional 1,224,734 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after buying an additional 791,516 shares in the last quarter. Amundi raised its holdings in Intuitive Surgical by 29.7% during the third quarter. Amundi now owns 3,227,472 shares of the medical equipment provider’s stock valued at $1,451,362,000 after buying an additional 739,444 shares in the last quarter. Sands Capital Management LLC raised its holdings in Intuitive Surgical by 77.0% during the third quarter. Sands Capital Management LLC now owns 1,341,109 shares of the medical equipment provider’s stock valued at $599,784,000 after buying an additional 583,539 shares in the last quarter. Finally, Victory Capital Management Inc. raised its holdings in Intuitive Surgical by 41.3% during the third quarter. Victory Capital Management Inc. now owns 1,941,310 shares of the medical equipment provider’s stock valued at $868,212,000 after buying an additional 567,483 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 2.9%

ISRG stock opened at $412.26 on Tuesday. Intuitive Surgical, Inc. has a twelve month low of $411.83 and a twelve month high of $603.88. The company has a market cap of $146.01 billion, a PE ratio of 49.97, a price-to-earnings-growth ratio of 3.39 and a beta of 1.46. The business’s 50-day simple moving average is $452.19 and its 200 day simple moving average is $504.81.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period last year, the business earned $1.81 earnings per share. The firm’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ISRG. Argus cut their target price on Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Robert W. Baird raised their target price on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Raymond James Financial cut their target price on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a report on Wednesday, April 22nd. BTIG Research restated a “buy” rating and set a $574.00 target price on shares of Intuitive Surgical in a report on Wednesday, April 22nd. Finally, Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 30th. Nineteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $576.71.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares of the company’s stock, valued at $782,321.13. This trade represents a 28.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $446.95, for a total value of $178,780.00. Following the sale, the executive vice president directly owned 6,120 shares in the company, valued at approximately $2,735,334. This trade represents a 6.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 4,833 shares of company stock valued at $2,357,582 in the last ninety days. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.